Serum gastrin levels in patients with intestinal and diffuse type of gastric cancer
1991

Serum Gastrin Levels in Gastric Cancer Patients

Sample size: 87 publication Evidence: moderate

Author Information

Author(s): S. Rakic, M.N. Milicevic

Primary Institution: Institute of Digestive Diseases, Belgrade University School of Medicine

Hypothesis

Does the histologic type of gastric cancer affect serum gastrin levels?

Conclusion

Patients with gastric cancer, especially of the intestinal type, have higher serum gastrin levels compared to normal subjects.

Supporting Evidence

  • Gastrin levels in patients with intestinal gastric cancer were significantly higher than in controls.
  • Gastrin levels in patients with diffuse gastric cancer were also higher than in controls.
  • 63% of patients with intestinal gastric cancer had elevated gastrin levels compared to the control group.

Takeaway

People with stomach cancer have more of a substance called gastrin in their blood, especially if their cancer is of a certain type.

Methodology

Fasting serum gastrin levels were measured in patients with gastric cancer and normal subjects using radioimmunoassay.

Limitations

The study excluded patients with potential causes for hypergastrinemia, which may limit the generalizability of the findings.

Participant Demographics

61 patients with gastric cancer (20 diffuse type, 41 intestinal type) and 26 normal subjects.

Statistical Information

P-Value

0.07

Statistical Significance

p<0.00001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication